Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction

Phase 4

Completed

• Conditions: Analgesia After ACL Reconstruction
• Interventions: Drug: 0.5% Bupivacaine; Drug: 0.25% Bupivacaine

• Registration Number: NCT01593566
• Lead Sponsor: Mahidol University

Brief Summary

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Study First Submitted: 2012-05-04
• Study First Submitted QC: 2012-05-07
• Study First Posted: 2012-05-08
• Primary Completion: 2013-04
• Study Completion: 2013-06
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-08
• Last Update Posted: 2015-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients scheduled for ACL reconstruction
• ASA physical status I-II
• Body weight > or = 50 kg.

Exclusion Criteria

• Patients with redo ACL reconstruction
• Contraindication to neuraxial block
• allergy to local anesthetics, sulfa, NSAIDs, morphine, paracetamol
• Patients with communication problem

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
0.5% bupivacaine	0.5% Bupivacaine	femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine
0.25% bupivacaine	0.25% Bupivacaine	femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine

Primary Outcome Measures

Name	Time	Method
time to first analgesic requirement	48 hr

Secondary Outcome Measures

Name	Time	Method
pain score scale	48 hr

Trial Locations

Locations (1)

Faculty of Medicine Siriraj Hospital, Mahidol University; 🇹🇭 Bangkok, Thailand